VEGFA and neoplasm: Therefore, anti-angiogenic therapy blocking VEGF may break this vicious cycle, reshape abnormal tumor microenvironment, improve cell hypoxia, and increase the sensitivity and efficacy of radiotherapy and chemotherapy drugs.[35] Endostar is an angiogenesis inhibiting neovascularization antitumor targeted drug developed by Chinese scientists in 1999.